ARCHIVES

Rauscher Responds To Criticism

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | March 21, 1975

Download PDF Visit The Full Archive

Related Articles

Colorectal, Lung Cancer Screening Techniques Show No Mortality Improvement, Conferences Find

December 1, 1978

DeVita Recommends Carcinogenesis Testing Program Be Moved to NIEHS

May 23, 1980

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005

Includes January Business & Regulatory Report (8-page issue).

January 31, 2003

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011